Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases

논문상세정보
' Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Akkermansia
  • Diabetes mellitus
  • Obesity
  • Peptidoglycan
  • lipopolysaccharides
  • type 2
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,527 0

0.0%

' Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases' 의 참고문헌

  • Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway
    Chen ML [2017]
  • Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB
    Seldin MM [2016]
  • Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
  • The short-chain fatty acid acetate in body weight control and insulin sensitivity
  • Supplementation with Akkermansia muciniphila in overweight and obese human volunteers : a proof-of-concept exploratory study
    Depommier C [2019]
  • Short-chain fatty acids in control of body weight and insulin sensitivity
  • Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population
    Ahmadi SF [2015]
  • Resveratrol attenuates trimethylamine-N-oxide(TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota
    Chen ML [2016]
  • Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
    Clarke TB [2010]
  • Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice
  • Plasma trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes
    Croyal M [2020]
  • Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis
  • Nonlethal inhibition of gut microbial trimethylamine N-oxide production improves cardiac function and remodeling in a murine model of heart failure
    Organ CL [2020]
  • Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis
    Wang Z [2015]
  • Nod1 ligands induce site-specific vascular inflammation
    Nishio H [2011]
  • NOD2 mutations and Crohn's disease : are Paneth cells and their antimicrobial peptides the link?
    Grimm MC [2004]
  • NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice
  • NOD1 activators link innate immunity to insulin resistance
  • Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4
  • Microbial translocation in type 2 diabetes : when bacterial invaders overcome host defence in human obesity
    Jensen BA [2020]
  • Metabolic endotoxemia initiates obesity and insulin resistance
    Cani PD [2007]
  • Low-density lipoprotein receptor signaling mediates the triglyceride-lowering action of Akkermansia muciniphila in genetic-induced hyperlipidemia
    Shen J [2016]
  • Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk
    Heianza Y [2020]
  • Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat diet
    Sakai T [2013]
  • Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes : molecular mechanisms and probiotic treatment
    Amar J [2011]
  • Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
    Koeth RA [2013]
  • Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
    Tang WH [2013]
  • Interaction between microbiota and immunity in health and disease
    Zheng D [2020]
  • Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk
    Zhu W [2016]
  • Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
    Li Z [2019]
  • Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
    Wang, Z. [2011]
  • Effects of probiotic supplementation on serum trimethylamine-N-oxide level and gut microbiota composition in young males: a double-blinded randomized controlled trial
    Chen S [2020]
  • Deficiency of Nucleotide-binding oligomerization domain-containing proteins(NOD)1 and 2 reduces atherosclerosis
    Vlacil AK [2020]
  • Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance
    Denou E [2015]
  • Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
    Everard, A. [2013]
  • Chronic stimulation of Nod2 mediates tolerance to bacterial products
    Hedl M [2007]
  • Bacteria to alleviate metabolic syndrome
    Anhê FF [2019]
  • Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-/-mice
    Li J [2016]
  • Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
    Greer RL [2016]
  • A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice [Internet]
    Plovier H [2017]
  • 3, 3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice
    Wang G [2020]
  • 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors : derivation in the MESA(Multi-Ethnic Study of Atherosclerosis)with validation in the HNR(Heinz Nixdorf Recall)study and the DHS(Dallas Heart Study)